Webinar: From Utah the U.K.—Why Companies Should Consider an IPO on the London Stock Exchange

May 14, 2021

On May 12, 2021, BioUtah presented a webinar featuring representatives of the banking firm, Stifel, as well as James McCullough, CEO of Renalytix, a Utah based company. The webinar presented the opportunity for Utah companies to raise capital through an offering on London Stock Exchange’s AIM platform. Renalytix is one of the most successful companies in years to do just that skipping the traditional process of raising early stage and venture capital.

If you did not have the opportunity to tune in, you can click on the link below to watch the full one hour webinar. It is a unique opportunity for raising capital.